Estland - estisk - Ravimiamet

zentiva k.s. - salmeterool+flutikasoon - annustatud inhalatsioonipulber - 50mcg+250mcg 1annus 60annus 3tk; 50mcg+250mcg 1annus 60annus 1tk; 50mcg+250mcg 1annus 60annus 10tk

Estland - estisk - Ravimiamet

novartis baltics sia - budesoniid - inhalatsioonipulber kõvakapslis - 400mcg 60tk

Estland - estisk - Ravimiamet

novartis baltics sia - budesoniid - inhalatsioonipulber kõvakapslis - 200mcg 60tk

Estland - estisk - Ravimiamet

meda pharma gmbh & co. kg - salbutamool - inhalatsioonipulber - 100mcg 1annus 200annus 1tk

Estland - estisk - Ravimiamet

astrazeneca ab - formoterool+budesoniid - inhalatsiooniaerosool, suspensioon - 4,5mcg+160mcg 1mõõtannus 120mõõtannus

Estland - estisk - Ravimiamet

zentiva k.s. - salmeterool+flutikasoon - annustatud inhalatsioonipulber - 50mcg+500mcg 1annus 60annus 1tk; 50mcg+500mcg 1annus 60annus 10tk; 50mcg+500mcg 1annus 60annus 2tk

Den europeiske union - estisk - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Den europeiske union - estisk - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Estland - estisk - Ravimiamet

narodowe centrum badan jadrowych - naatriumjodiid (131i) - kõvakapsel - 1tk

Estland - estisk - Ravimiamet

sandoz pharmaceuticals d.d. - formoterool - inhalatsioonipulber kõvakapslis - 12mcg 30tk